United States: FDA Publishes Long-Awaited Draft Guidance On 510(k) Requirements For Modified Devices


On August 5, 2016, the US Food and Drug Administration (FDA) posted two long-awaited draft guidance documents intended to help industry and FDA staff determine whether a new premarket notification (510(k)) is required upon the modification of a legally marketed medical device. 

In Depth

Under FDA regulations, a device manufacturer must submit a new 510(k) when a modification "could significantly affect the safety or effectiveness of the device" or represents a "major change or modification" in the intended use of the device. 21 C.F.R. § 807.81(a)(3). Because the quoted terms are not defined in the regulations, FDA and manufacturers often reach differing conclusions with respect the same post-modification device. The draft guidance documents—entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (hereinafter, the General Guidance) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (hereinafter, the Software Guidance), respectively—outline a series of detailed considerations that are intended to facilitate consistent interpretation of the applicable standards by FDA staff and manufacturers. As the titles of the documents suggest, the General Guidance applies generally to manufacturers of medical devices subject to the 510(k) requirement (including stand-alone software that is a medical device), while the Software Guidance applies to changes to software changes to devices.

The General Guidance document is lengthy (76 pages) and articulates policies that are largely consistent with FDA's 1997 guidance, which remains FDA's most recent official articulation of its policy on this issue. The General Guidance sets forth several "guiding principles" for determining whether a new 510(k) is required:

  • Modifications made with the intent to significantly improve safety or effectiveness of a device. If a modification is made with the intent to significantly improve the safety or effectiveness of the device, a new 510(k) is likely required.
  • "Could significantly affect" evaluation and the role of testing. The manufacturer should conduct a risk-based assessment of whether a change could significantly affect the device's safety or effectiveness, either positively or negatively. The risk-based assessment should identify and analyze all new risks and changes in known risks resulting from the modification.
  • Unintended consequences of changes. Manufacturers should consider whether there are any unintended consequences or effects associated with the modification.
  • Use of risk management. Hazards and hazardous situations, risk estimation, risk acceptability, risk control, risk/benefit analysis and overall risk evaluation are all concepts that can be applied during the design and development of a device.
  • Evaluating simultaneous changes. Because many simultaneous changes may be considered at once, each change should be assessed separately, as well as in aggregate.
  • Appropriate comparative device and cumulative effect of changes. A manufacturer's risk-based assessment should compare the modified device to the version of the device that was found to be substantially equivalent in their most recently cleared 510(k).
  • Documentation requirement. The FDA's Quality System Regulation (QSR) requires the documentation of device changes.
  • 510(k) submissions for modified devices. When a new 510(k) is submitted for a device with multiple modifications, that 510(k) should describe all changes that trigger the requirement for a new 510(k). That 510(k) should also describe other modification(s) since the last cleared 510(k) that would have been documented as part of an original 510(k) for that device.
  • Substantial equivalence determinations. Even if a manufacturer follows this guidance and submits a new 510(k), a substantially equivalent determination is not assured.

The General Guidance also offers detailed flow charts and narrative text to guide manufacturers through FDA's recommended logic scheme, as well as dozens of examples illustrating the application of the proposed framework. Given the level and depth of information provided, the FDA divides the General Guidance framework into shorter schemes that describe how manufacturers should assess

  • Labeling changes
  • Technology, engineering and performance changes
  • Materials changes
  • Technology, engineering, performance and materials changes for in vitro diagnostic devices (IVDs)
  • Considerations for risk assessments of modified devices

The Software Guidance includes much of the same information as the General Guidance (e.g., the same "guiding principles"). The Software Guidance also offers the following overarching guidance specific to the review of modifications to software:

  • Software changes made solely to strengthen cybersecurity, protect information and reduce disruption in service without impacting the performance of the device likely do not require a new 510(k).
  • Software changes made solely to restore the device to its most recently cleared specifications likely do not require a new 510(k).
  • Subject to certain outlined criteria, software changes that introduce a new or alter an existing cause or type of hazardous situation that is not mitigated in the most recently cleared device likely require a new 510(k). A hazardous situation exists when there is a potential for exposure to physical injury or damage to health. The cause of a hazardous situation should be identified and defined by the manufacturer in the device's risk management file.
  • Software changes that introduce new risk control measures or implement changes to prevent significant harm likely require a new 510(k). Note, however, that a new 510(k) is likely not required as a result of a manufacturer implementing additional risk control measures, provided such measures have not been added in response to a new, modified or previously known hazardous situation or causes thereof.
  • Software changes that may significantly affect clinical functionality or performance specifications that are directly associated with a device's intended use likely require a new 510(k).

The Software Guidance includes dozens of examples illustrating FDA's application of these principles.

Comments on the draft guidance documents should be submitted to the FDA by November 7, 2016.


The agency's position with respect to the 510(k) requirement for modified devices has long been the subject of angst within industry, particularly since the agency's 2011 publication of a (subsequently withdrawn) guidance document that, in industry's view, would have substantially increased the number of device modifications triggering the requirement for a new 510(k). In the General and Software Guidance documents, the FDA takes the feedback it has received from industry into account in articulating its overarching considerations. That being said, medical device manufacturers of all types—as well as manufacturers of certain products that may soon be subject to regulation as medical devices (e.g., developers of laboratory-developed tests (LDTs))—should carefully review the principles articulated in the documents and consider offering comments to the agency, particularly insofar as the agency takes a position that appears to unreasonably subject a group of modifications to additional regulatory scrutiny.

FDA Publishes Long-Awaited Draft Guidance on 510(k) Requirements for Modified Devices

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.